Washington Trust Advisors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,392	Closed	-$428K	–	918
2022 Q2	$428K	Sell	4,392 -2,655	-38%	-$259K	0.04%	142
2022 Q1	$661K	Sell	7,047 -440	-6%	-$41.3K	0.05%	135
2021 Q4	$638K	Buy	+7,487	New	+$638K	0.04%	144